These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 399243)

  • 21. Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1985 Nov; 84(5):643-8. PubMed ID: 3877452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative activity of cefixime and cefaclor in an in vitro model simulating human pharmacokinetics.
    Nies BA
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):558-61. PubMed ID: 2504600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Subinhibitory activity of cefaclor and cephalexin (author's transl)].
    Shah PM; Staszewski S
    Infection; 1979; 7 Suppl 6():543-6. PubMed ID: 399246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of Ro 15-8074 and Ro 19-5247 in comparison to cefaclor and cefalexin.
    Simon C
    Infection; 1987; 15(2):122-4. PubMed ID: 3596808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bacteriological in vitro investigations with cefaclor. Correlation of inhibition zone diameter and minimal inhibitory concentration (author's transl)].
    Grimm H
    Infection; 1979; 7 Suppl 6():540-2. PubMed ID: 399245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
    Barry AL; Schoenknect FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
    Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-vitro activity of cefaclor, cephalexin and ampicillin against 2458 clinical isolates of Haemophilus influenzae.
    Powell M; Williams JD
    J Antimicrob Chemother; 1988 Jan; 21(1):27-31. PubMed ID: 3258594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [In vitro activity of cefaclor against Haemophilus influenzae in comparison to various oral chemotherapeutic agents (author's transl)].
    Braveny I
    Infection; 1979; 7 Suppl 6():532-9. PubMed ID: 317812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro studies of cefamandole.
    Bodey GP; Weaver S
    Antimicrob Agents Chemother; 1976 Mar; 9(3):452-7. PubMed ID: 769679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli.
    Verbist L
    Antimicrob Agents Chemother; 1976 Oct; 10(4):657-63. PubMed ID: 984801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro activity of oral cephalosporins (author's transl)].
    Wiedemann B; Flensberg T
    Infection; 1979; 7 Suppl 6():551-3. PubMed ID: 399247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility of clinical isolates of Enterobacteriaceae to BL-S640, a new oral cephalosporin.
    Watanakunakorn C; Bannister T; Glotzbecker C
    Antimicrob Agents Chemother; 1975 Mar; 7(3):381-5. PubMed ID: 1137392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity of Gram-negative bacilli to ampicillin after six years' clinical use.
    Slocombe B; Sutherland R
    J Clin Pathol; 1969 Nov; 22(6):644-8. PubMed ID: 4983462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance to gentamicin: a growing concern.
    Siebert WT; Moreland NJ; Williams TW
    South Med J; 1977 Mar; 70(3):289-92. PubMed ID: 322294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro evaluation of cefoxitin and cefamandole.
    Adams HG; Stilwell GA; Turck M
    Antimicrob Agents Chemother; 1976 Jun; 9(6):1019-24. PubMed ID: 820241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of cefaclor, a new orally administered cephalosporin antibiotic.
    Santoro J; Levison ME
    Antimicrob Agents Chemother; 1977 Sep; 12(3):442-3. PubMed ID: 907337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 1. Molecular and genetic characterization of R-factors (author's transl)].
    Schmid B; Kayser FH
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):371-83. PubMed ID: 779353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A national collaborative study of the in vitro activity of oral cephalosporins and loracarbef (LY 163892). Australian Group for the Study of Antimicrobial Resistance (AGAR).
    Benn RA; Fernandes CJ; Nimmo GR
    Pathology; 1997 Feb; 29(1):79-83. PubMed ID: 9094185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined action of beta-lactum antibiotics against gram-negative bacilli.
    Bobrowski MM; Gebicka K; Borowski J
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(2):129-40. PubMed ID: 4199760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.